| Dr Elizabeth A Buys, MD | |
|
119 Hendersonville Rd, Asheville, NC 28803-2868 | |
| (828) 771-5500 | |
| (828) 257-4750 |
| Full Name | Dr Elizabeth A Buys |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 119 Hendersonville Rd, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669589404 | NPI | - | NPPES |
| 2017437 | Other | NC | PTAN |
| 166589404 | Medicaid | NC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain Area Health Education Center Inc | 0143206599 | 129 |
News Archive
An analysis of survey data found no significant racial differences in various aspects of the quality of end-of-life care, although survey respondents reported deficiencies in the quality of end-of-life care for both black and white patients who died, including unmet symptom needs, problems with communication and less than optimal decision-making, according to an article published by JAMA Internal Medicine.
Bioengineers and public health researchers at Harvard University have developed a novel spraying method for delivering the most common tuberculosis (TB) vaccine, providing a new low-cost and scaleable technique that offers needle-free delivery and greater stability at room temperature than existing methods.
Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host an Investor Day in New York to discuss the Company's irritable bowel syndrome (IBS) program, including its novel, oral product SYN-010, targeting constipation-predominant IBS (C-IBS).
On July 1, the Texas A&M Engineering Experiment Station's National Center for Therapeutics Manufacturing received funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals to help find a way to prevent the SARS-CoV-2 virus from binding to cells, protecting people from future infections.
A new study from Case Western Reserve University's Frances Payne Bolton School of Nursing emphasizes the importance of having discussions related to quality of life before becoming critically ill.
› Verified 5 days ago
| Entity Name | Mountain Area Health Education Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952356388 PECOS PAC ID: 0143206599 Enrollment ID: O20040625000988 |
News Archive
An analysis of survey data found no significant racial differences in various aspects of the quality of end-of-life care, although survey respondents reported deficiencies in the quality of end-of-life care for both black and white patients who died, including unmet symptom needs, problems with communication and less than optimal decision-making, according to an article published by JAMA Internal Medicine.
Bioengineers and public health researchers at Harvard University have developed a novel spraying method for delivering the most common tuberculosis (TB) vaccine, providing a new low-cost and scaleable technique that offers needle-free delivery and greater stability at room temperature than existing methods.
Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host an Investor Day in New York to discuss the Company's irritable bowel syndrome (IBS) program, including its novel, oral product SYN-010, targeting constipation-predominant IBS (C-IBS).
On July 1, the Texas A&M Engineering Experiment Station's National Center for Therapeutics Manufacturing received funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals to help find a way to prevent the SARS-CoV-2 virus from binding to cells, protecting people from future infections.
A new study from Case Western Reserve University's Frances Payne Bolton School of Nursing emphasizes the importance of having discussions related to quality of life before becoming critically ill.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth A Buys, MD 119 Hendersonville Rd, Asheville, NC 28803-2868 Ph: (828) 771-5500 | Dr Elizabeth A Buys, MD 119 Hendersonville Rd, Asheville, NC 28803-2868 Ph: (828) 771-5500 |
News Archive
An analysis of survey data found no significant racial differences in various aspects of the quality of end-of-life care, although survey respondents reported deficiencies in the quality of end-of-life care for both black and white patients who died, including unmet symptom needs, problems with communication and less than optimal decision-making, according to an article published by JAMA Internal Medicine.
Bioengineers and public health researchers at Harvard University have developed a novel spraying method for delivering the most common tuberculosis (TB) vaccine, providing a new low-cost and scaleable technique that offers needle-free delivery and greater stability at room temperature than existing methods.
Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host an Investor Day in New York to discuss the Company's irritable bowel syndrome (IBS) program, including its novel, oral product SYN-010, targeting constipation-predominant IBS (C-IBS).
On July 1, the Texas A&M Engineering Experiment Station's National Center for Therapeutics Manufacturing received funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals to help find a way to prevent the SARS-CoV-2 virus from binding to cells, protecting people from future infections.
A new study from Case Western Reserve University's Frances Payne Bolton School of Nursing emphasizes the importance of having discussions related to quality of life before becoming critically ill.
› Verified 5 days ago
Dr. Ruchi Patel Moore, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 41 Oakland Rd, Suite 200, Asheville, NC 28801 Phone: 828-253-5381 Fax: 828-253-9087 | |
Dr. Ursula Fritzi Harkness, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 119 Hendersonville Rd, Asheville, NC 28803 Phone: 828-771-5504 Fax: 828-771-5479 | |
Dr. Summer Kimberly Gilmer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 41 Oakland Road, Suite 200, Asheville, NC 28801 Phone: 828-253-5381 Fax: 828-253-9087 | |
Elizabeth S. Garbarino, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 40 N Merrimon Ave, Asheville, NC 28804 Phone: 828-575-9562 Fax: 828-575-2884 | |
Sarah Jones, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 143 Asheland Ave, Asheville, NC 28801 Phone: 828-258-9191 | |
Patricia Mae Engel Overcarsh, M.D., M.P.H. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 119 Hendersonville Rd, Asheville, NC 28803 Phone: 828-771-5500 Fax: 828-257-4750 | |
Bhaskari Burra, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 119 Hendersonville Rd, Asheville, NC 28803 Phone: 828-771-5500 Fax: 828-257-4750 |